PMID: 8604440Mar 1, 1996Paper

Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial

Progress in Cardiovascular Diseases
J A ReiffelESVEM Investigators

Abstract

Because not all laboratories use the monitoring and stimulation protocols used in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial, we reanalyzed the ESVEM patients' data using alternative, commonly used Holter monitor (HM) and programmed stimulation efficacy criteria to determine if different criteria would have changed the trial's conclusions. Also, because beta-blocker use and coronary artery disease frequency were not equally distributed between the two limbs in ESVEM, we reanalyzed the ESVEM data adjusting for the possible effect of these variables. In the HM limb, drug efficacy in the original ESVEM analysis was declared by reduction of total premature ventricular complexes (PVCs) by 70%, pairs by 80%, runs of 3 to 15 beats by 90%, and all ventricular tachycardia (VT) more than 15 beats by 100%. In this analysis, we examine outcome in subjects meeting two more stringent sets of criteria, (1) reduction of total PVCs by 70%, of pairs by 80%, and of all VT by 100% (new criteria set 1) and (2) reduction of total PVCs by 80%, of pairs by 90%, and of all VT by 100% (new criteria set 2). In electrophysiology (EPS) limb patients, we compared arrhythmia recurrence when efficacy was declared with tr...Continue Reading

References

Mar 1, 1979·The American Journal of Cardiology·M E Josephson, L N Horowitz
Jan 1, 1986·The American Journal of Cardiology
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Jan 1, 1988·Journal of the American College of Cardiology·M J CooperD L Ross
Jan 7, 1988·The New England Journal of Medicine·D J WilberJ N Ruskin
Sep 1, 1982·The American Journal of Cardiology·T B GraboysR DeSilva
Jun 16, 1983·The New England Journal of Medicine·C D SwerdlowJ W Mason
Sep 1, 1982·The American Journal of Cardiology·F D LivelliJ I Gliklich
Mar 1, 1995·Pacing and Clinical Electrophysiology : PACE·S L Winters, J H Curwin
Apr 1, 1995·Circulation·L S Gettes
Aug 12, 1993·The New England Journal of Medicine·D E Ward, A J Camm

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·J J Goldberger
Mar 1, 1996·Progress in Cardiovascular Diseases·J W MasonD Mann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.